OPRX logo

OPRX
OptimizeRx Corp

1,145
Mkt Cap
$116.51M
Volume
81,604.00
52W High
$22.25
52W Low
$5.54
PE Ratio
23.83
OPRX Fundamentals
Price
$6.25
Prev Close
$6.21
Open
$6.18
50D MA
$6.60
Beta
1.60
Avg. Volume
443,559.62
EPS (Annual)
$0.2701
P/B
0.91
Rev/Employee
$822,774.44
$235.66
Loading...
Loading...
News
all
press releases
Should You Add OPRX Stock to Your Portfolio Pre-Q1 Earnings?
OptimizeRx nears Q1 earnings amid declining revenue forecasts, softer trends and a cautious outlook, raising questions on near-term upside.
Zacks·5d ago
News Placeholder
More News
News Placeholder
OptimizeRx (NASDAQ:OPRX) Lowered to "Hold" Rating by Zacks Research
Zacks Research lowered OptimizeRx from a "strong-buy" rating to a "hold" rating in a report on Monday...
MarketBeat·6d ago
News Placeholder
OptimizeRx (OPRX) Projected to Post Earnings on Tuesday
OptimizeRx (NASDAQ:OPRX) will be releasing its Q1 2026 earnings after the market closes on Tuesday, May 12. (View Earnings Report at...
MarketBeat·7d ago
News Placeholder
Earnings Preview: OptimizeRx Corp. (OPRX) Q1 Earnings Expected to Decline
OptimizeRx (OPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·7d ago
News Placeholder
Are Investors Undervaluing OptimizeRx (OPRX) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks·8d ago
News Placeholder
SNDK's Q3 Earnings Beat Estimates, Revenues Rise on Datacenter Surge
Sandisk smashes Q3 FY26 estimates as revenues soar 251%, margins jump and a $6B buyback lands ahead of a big Q4 guide.
Zacks·11d ago
News Placeholder
Smith Micro Software, Inc. (SMSI) Reports Q1 Loss, Tops Revenue Estimates
Smith Micro Software (SMSI) delivered earnings and revenue surprises of -100.00% and +0.50%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·13d ago
News Placeholder
Cadence Design Systems (CDNS) Q1 Earnings and Revenues Top Estimates
Cadence (CDNS) delivered earnings and revenue surprises of +4.26% and +1.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks·15d ago
News Placeholder
OptimizeRx vs. GoodRx: Which Digital Health Stock is the Better Buy?
OPRX edges past GDRX with AI-driven platform momentum, stronger estimates and lower valuation despite near-term revenue headwinds.
Zacks·18d ago
News Placeholder
Will Enterprise Deals & MedTech Momentum Fuel OPRX's Growth Engine?
OptimizeRx rides AI-driven engagement gains, as oncology pilots scale to multi-brand deals and med tech traction fuels rising enterprise investment momentum.
Zacks·19d ago
<
1
2
...
>

Latest OPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.